Smith & Nephew's JOURNEY II UK Knee System Executes Surgeries
Zacks Investment Research | Dec 04, 2019 07:50AM ET
Smith & Nephew (LON:SN), plc (NYSE:SNN) recently announced the complete execution of the first-ever surgeries using its new JOURNEY II Unicompartmental Knee (UK) System.
This development is expected to provide a major impetus to the company’s Orthopaedics segment.
More on JOURNEY II UK System
The system integrates both an enhanced size range and lateral specific implant, which facilitates surgeons performing partial knee arthroplasty to maintain the shape, position and motion of a normal knee joint. The new JOURNEY II UK system has been developed to provide swifter recovery, better functionalityand improved patient outcomes than other unicompartmental options currently available in the market.
The system merges a simplistic surgical technique with an implant offering additional sizes for optimum coverage. The system is also cost-effective as it results in reduced OR footprint. Moreover, when used with the NAVI Handheld Robotics and VISIONAIRE Patient Matched Instrumentation, Smith & Nephew offers healthcare experts an unparalleled solution portfolio for partial knee replacements.
JOURNEY II UK leverages on the most superior technology from Smith & Nephew’s successful JOURNEY II platform as well as its ZUK Unicompartmental Knee.
Global commercial rollout of JOURNEY II UK is slated to begin in early 2020.
Market Prospects
Per Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.